Skip to main content
NVDA+0.61%AAPL-1.02%GOOGL-1.48%MSFT-0.87%AMZN-1.67%TSM-1.18%SPCX-2.52%META+0.48%AVGO-1.41%TSLA+0.66%SKHY-1.14%BRK-B+0.06%LLY+0.29%MU+0.13%JPM-1.87%WMT-0.56%AMD+1.78%V-0.16%XOM+2.24%JNJ-0.81%ASMLa-1.02%0700.HK+1.90%MA-0.34%INTC+1.05%ABBV+0.71%1398.HK-2.09%CSCO+0.55%CVX+1.82%BAC-0.82%ORCL-0.51%COST-1.38%KO-1.07%DELL+3.10%CAT-0.35%HSBA.L-2.33%0005.HK-3.21%PG+0.43%UNH-1.79%LRCX-2.68%AP2d-2.19%AMAT-1.72%1816.HK-0.46%3988.HK-2.13%NFLX-2.97%GE-2.92%MS-2.73%0857.HK+0.60%HD-1.65%PM-0.36%0939.HK-2.83%USDJPY+1.02%NZDUSD-1.00%CHFJPY+0.79%USDTHB+0.72%NZDCHF-0.70%CADJPY+0.68%NZDCAD-0.66%GBPNZD+0.65%AUDUSD-0.63%GBPJPY+0.63%EURUSD-0.51%EURNZD+0.50%EURJPY+0.48%GBPTRY+0.41%PLNJPY+0.41%AUDJPY+0.40%NOKJPY+0.39%AUDNZD+0.38%GBPUSD-0.36%USDCAD+0.34%NZDMXN-0.34%GBPHKD+0.32%USDCHF+0.31%AUDCHF-0.31%SGDJPY+0.31%GBPMXN-0.28%AUDCAD-0.27%GBPAUD+0.25%USDTRY+0.25%USDSEK+0.23%NZDSGD-0.20%USDSGD+0.20%EURCAD-0.19%EURCHF-0.18%USDILS+0.16%GBPZAR-0.16%EURSEK+0.15%EURAUD+0.14%EURSGD+0.12%EURGBP-0.12%USDNOK+0.12%AUDDKK-0.11%EURCZK+0.11%USDPLN+0.11%CHFNOK-0.08%AUDNOK-0.08%USDDKK+0.07%GBPCHF-0.07%EURHKD-0.07%USDMXN+0.07%USDCNH+0.07%EURZAR-0.05%CADCHF-0.04%USDCOP-0.04%EURNOK+0.04%EURCNH-0.04%EURPLN+0.03%CHFSEK+0.03%USDHKD+0.02%USDZAR+0.02%GBPSGD+0.02%GBPCAD-0.02%NZDJPY+0.02%AUDSGD+0.01%EURDKK0.00%CHFSGD0.00%USOIL+2.93%COCOA-2.53%UKOIL+1.67%COFFEE-1.54%W1+1.38%S1+0.95%SUGAR-0.88%XNGUSD+0.87%C1+0.76%HG1+0.53%COTTON-0.48%XAUUSD-0.21%BTCUSD-2.23%ETHUSD-3.75%USDTUSD-0.03%XRPUSD-2.61%SOLUSD-3.23%TRXUSDT-0.68%ZECUSDT-3.71%DOGEUSD-2.60%XMRUSDT+0.32%LINKUSD-2.36%XLMUSD+0.39%BCHUSDT-1.21%UNIUSD-2.61%LTCUSD-2.68%HBARUSDT+0.80%TONUSD+26.79%SUIUSD-2.80%TAOUSDT-3.05%AAVEUSD-2.58%DOTUSDT-1.91%ICPUSDT-7.54%ONDOUSDT-3.49%WLDUSDT-2.09%ARBUSDT+10.78%ATOMUSDT-1.91%JUPUSDT-4.72%INJUSDT-9.94%STXUSDT-3.11%FETUSDT-4.66%PYTHUSDT-4.25%TIAUSDT-5.86%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-1.70%GRTUSDT-3.93%POLUSDT+0.86%WIFUSDT-4.80%IOTAUSDT-5.88%AXSUSDT-3.31%FARTCOINUSDT-1.64%EOSUSDT-4.69%DYDXUSDT-5.95%ORDIUSDT-2.11%GALAUSDT-2.06%NOTUSDT-2.37%RONINUSDT-14.59%NVDA+0.61%AAPL-1.02%GOOGL-1.48%MSFT-0.87%AMZN-1.67%TSM-1.18%SPCX-2.52%META+0.48%AVGO-1.41%TSLA+0.66%SKHY-1.14%BRK-B+0.06%LLY+0.29%MU+0.13%JPM-1.87%WMT-0.56%AMD+1.78%V-0.16%XOM+2.24%JNJ-0.81%ASMLa-1.02%0700.HK+1.90%MA-0.34%INTC+1.05%ABBV+0.71%1398.HK-2.09%CSCO+0.55%CVX+1.82%BAC-0.82%ORCL-0.51%COST-1.38%KO-1.07%DELL+3.10%CAT-0.35%HSBA.L-2.33%0005.HK-3.21%PG+0.43%UNH-1.79%LRCX-2.68%AP2d-2.19%AMAT-1.72%1816.HK-0.46%3988.HK-2.13%NFLX-2.97%GE-2.92%MS-2.73%0857.HK+0.60%HD-1.65%PM-0.36%0939.HK-2.83%USDJPY+1.02%NZDUSD-1.00%CHFJPY+0.79%USDTHB+0.72%NZDCHF-0.70%CADJPY+0.68%NZDCAD-0.66%GBPNZD+0.65%AUDUSD-0.63%GBPJPY+0.63%EURUSD-0.51%EURNZD+0.50%EURJPY+0.48%GBPTRY+0.41%PLNJPY+0.41%AUDJPY+0.40%NOKJPY+0.39%AUDNZD+0.38%GBPUSD-0.36%USDCAD+0.34%NZDMXN-0.34%GBPHKD+0.32%USDCHF+0.31%AUDCHF-0.31%SGDJPY+0.31%GBPMXN-0.28%AUDCAD-0.27%GBPAUD+0.25%USDTRY+0.25%USDSEK+0.23%NZDSGD-0.20%USDSGD+0.20%EURCAD-0.19%EURCHF-0.18%USDILS+0.16%GBPZAR-0.16%EURSEK+0.15%EURAUD+0.14%EURSGD+0.12%EURGBP-0.12%USDNOK+0.12%AUDDKK-0.11%EURCZK+0.11%USDPLN+0.11%CHFNOK-0.08%AUDNOK-0.08%USDDKK+0.07%GBPCHF-0.07%EURHKD-0.07%USDMXN+0.07%USDCNH+0.07%EURZAR-0.05%CADCHF-0.04%USDCOP-0.04%EURNOK+0.04%EURCNH-0.04%EURPLN+0.03%CHFSEK+0.03%USDHKD+0.02%USDZAR+0.02%GBPSGD+0.02%GBPCAD-0.02%NZDJPY+0.02%AUDSGD+0.01%EURDKK0.00%CHFSGD0.00%USOIL+2.93%COCOA-2.53%UKOIL+1.67%COFFEE-1.54%W1+1.38%S1+0.95%SUGAR-0.88%XNGUSD+0.87%C1+0.76%HG1+0.53%COTTON-0.48%XAUUSD-0.21%BTCUSD-2.23%ETHUSD-3.75%USDTUSD-0.03%XRPUSD-2.61%SOLUSD-3.23%TRXUSDT-0.68%ZECUSDT-3.71%DOGEUSD-2.60%XMRUSDT+0.32%LINKUSD-2.36%XLMUSD+0.39%BCHUSDT-1.21%UNIUSD-2.61%LTCUSD-2.68%HBARUSDT+0.80%TONUSD+26.79%SUIUSD-2.80%TAOUSDT-3.05%AAVEUSD-2.58%DOTUSDT-1.91%ICPUSDT-7.54%ONDOUSDT-3.49%WLDUSDT-2.09%ARBUSDT+10.78%ATOMUSDT-1.91%JUPUSDT-4.72%INJUSDT-9.94%STXUSDT-3.11%FETUSDT-4.66%PYTHUSDT-4.25%TIAUSDT-5.86%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-1.70%GRTUSDT-3.93%POLUSDT+0.86%WIFUSDT-4.80%IOTAUSDT-5.88%AXSUSDT-3.31%FARTCOINUSDT-1.64%EOSUSDT-4.69%DYDXUSDT-5.95%ORDIUSDT-2.11%GALAUSDT-2.06%NOTUSDT-2.37%RONINUSDT-14.59%
ET

Entrada Therapeutics, Inc. (TRDA)

NASDAQ • Healthcare

$7.05
+$0.25 (+3.7%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$6.8
Previous Close$7.05
Day Range$6.72 - $7.07
Avg. Volume (3M)283.5K
Market Cap$260.4M
52 Week Range
$5.02$16.45
Next EarningsIn 51 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$898K100%
Gross Profitminus cost of goods$898K100%

Fundamentals & Financials

Revenue (TTM)
$4.6M
Net Income (TTM)
-$165.7M
EPS (TTM)
-$3.97
ROA (TTM)
-55.47%
Current Ratio
10.89

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+28.8%Q1 2026-$0.94
+10.4%Q2 2026-$0.95
-3.7%Q3 2026-$1.01
Next

Nov 5

in 51 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops intracellular medicines using its proprietary EEV platform, with $25.4 million of revenue in FY2025. The platform underpins oligonucleotide, antibody, and enzyme-based therapeutic programs and frames Entrada as a drug developer rather than a commercial biopharma company.

Name
Entrada Therapeutics, Inc.
CEO
Dipal Doshi
Website
www.entradatx.com
Industry
Healthcare
Year Founded
2016
Employees
152

Today's Snapshot

AI-generated

TRDA started the session flat at 7.05, while its sector was flat.

Trading Volume

Below 10d avg (326.0K)

40.4K

vs S&P 500 Today

Strong Underperformance

-4.63%

Updated: September 15, 2026 at 14:47 UTC

Technical Indicators

0 Buy2 Neutral6 Sell
Trading near $6.74, the technicals point to clear downside pressure with the market trading below a range of short-, medium- and long-term moving averages, including a much higher 200-day level, and both CCI and MACD signaling bearish momentum. ADX is low which indicates the decline lacks strong trend acceleration, yet ATR shows elevated percentage volatility and the pivot sits above price, reinforcing resistance. OBV is an outlier and shows some buying, but it does not offset the broader weakness. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$6.98 - $8.51
    Sell
  • RSI (14)45.19
    Neutral
  • Stochastic %K (14, 3, 3)40.66
    Neutral
  • MACD Level (12, 26)-0.07
    Sell

Peers & Related Assets

ALLOAllogene Therapeutics, Inc.
$1.780.0%
CAPRCapricor Therapeutics, Inc.
$8.81+5.3%
ARCTArcturus Therapeutics Holdings Inc.
$15.29+3.8%
AVIRAtea Pharmaceuticals, Inc.
$5.32+0.2%
VNDAVanda Pharmaceuticals Inc.
$5.15+1.2%
VYGRVoyager Therapeutics, Inc.
$3.190.0%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.